206 related articles for article (PubMed ID: 2135387)
1. Longitudinal study of patients with anticentromere antibody.
Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
[TBL] [Abstract][Full Text] [Related]
2. Clinical distribution of anticentromere antibody in Japanese patients.
Soma Y; Takehara K; Ishibashi Y
Dermatologica; 1989; 178(1):16-9. PubMed ID: 2645177
[TBL] [Abstract][Full Text] [Related]
3. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
Fritzler MJ; Kinsella TD
Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
[TBL] [Abstract][Full Text] [Related]
4. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
[TBL] [Abstract][Full Text] [Related]
5. [The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions].
Sato S; Takehara K; Ishibashi Y
Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):97-104. PubMed ID: 2072581
[TBL] [Abstract][Full Text] [Related]
6. Anticentromere antibody and Raynaud's phenomenon.
Czirják L; Schlammadinger J; Szegedi G
Dermatologica; 1991; 183(1):55. PubMed ID: 1769420
[No Abstract] [Full Text] [Related]
7. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
Goldman JA
Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
Kallenberg CG; Pastoor GW; Wouda AA; The TH
Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
[TBL] [Abstract][Full Text] [Related]
9. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
10. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
[TBL] [Abstract][Full Text] [Related]
11. [The clinical spectrum of patients with anticentromere antibodies].
Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
[TBL] [Abstract][Full Text] [Related]
12. A long-term longitudinal study of anticentromere antibodies.
Tramposch HD; Smith CD; Senecal JL; Rothfield N
Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
[TBL] [Abstract][Full Text] [Related]
13. Anticentromere antibody in localized scleroderma.
Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
[TBL] [Abstract][Full Text] [Related]
14. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
McCarty GA; Rice JR; Bembe ML; Barada FA
Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
[TBL] [Abstract][Full Text] [Related]
15. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
16. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma?
Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D
J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618
[TBL] [Abstract][Full Text] [Related]
17. The anticentromere antibody: disease specificity and clinical significance.
Powell FC; Winkelmann RK; Venencie-Lemarchand F; Spurbeck JL; Schroeter AL
Mayo Clin Proc; 1984 Oct; 59(10):700-6. PubMed ID: 6384675
[TBL] [Abstract][Full Text] [Related]
18. Serological markers in progressive systemic sclerosis: clinical correlations.
Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlation of anticentromere antibodies.
Zuber M; Gotzen R; Filler I
Clin Rheumatol; 1994 Sep; 13(3):427-32. PubMed ID: 7835004
[TBL] [Abstract][Full Text] [Related]
20. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
